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Background: Mounting evidence suggests that soluble oligomers of amyloid-β (oAβ) represent the pertinent
synaptotoxic form of Aβ in sporadic Alzheimer’s disease (AD); however, the mechanistic links between oAβ and
synaptic degeneration remain elusive. Most in vivo experiments to date have been limited to examining the toxicity
of oAβ in mouse models that also possess insoluble fibrillar Aβ (fAβ), and data generated from these models can
lead to ambiguous interpretations. Our goal in the present study was to examine the effects of soluble oAβ on
neuronal and synaptic structure in the amyloid precursor protein (APP) E693Q (“Dutch”) mouse model of AD, which
develops intraneuronal accumulation of soluble oAβ with no detectable plaques in AD-relevant brain regions. We
performed quantitative analyses of neuronal pathology, including dendrite morphology, spine density, and synapse
ultrastructure in individual hippocampal CA1 neurons.
Results: When assessing neuronal morphology and complexity we observed significant alterations in apical but not
in basal dendritic arbor length in Dutch mice compared to wild type. Moreover, Dutch mice exhibited a significant
decrease in dendritic arborization with a decrease in dendritic length and number of intersections at 120 μm and
150 μm from the soma, respectively. We next examined synaptic parameters and found that while there were no
differences in overall synaptic structure, Dutch mice displayed a significant reduction in the post-synaptic density
(PSD) length of synapses on mushroom spines, in comparison to wild type littermates.
Conclusion: The structural alterations to individual neurons in Dutch mice along with the changes in larger
dendritic spines support the Aβ oligomer hypothesis, which postulates that the early cognitive impairments that
occur in AD are attributed to the accumulation of soluble oAβ first affecting at the synaptic level with subsequent
structural disturbances and cellular degeneration.
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The neuropathological hallmarks of Alzheimer’s disease
(AD) include amyloid-β (Aβ) plaque accumulation, neuro-
fibrillary tangle formation, and synaptic and neuronal loss.
How these factors ultimately contribute to memory loss
and cognitive deficits that clinically characterize the dis-
ease remains unclear. In AD brains, Aβ can spontaneously
aggregate and thereby assume a variety of conformational
states ranging from monomers to soluble oligomers, pro-
tofibrils, and insoluble fibrils, which assemble to form
extracellular plaques [1,2]. Further characterization of this
array of Aβ conformations has proven critical for deci-
phering which of these may be neurotoxic. The insoluble
fibrillar Aβ (fAβ) found in the extracellular plaques in
post-mortem AD brains has long been postulated as the
initiating agent in the neurodegenerative cascade of the
disease. However, many recent studies have demonstrated
that the amount and distribution of amyloid plaques does
not correlate with synaptic or neuronal loss, and the onset
of cognitive decline in AD [3-9]. In contrast, soluble oligo-
meric Aβ assemblies (oAβ, also called Aβ-derived dif-
fusible ligands), which range in size from tetramers to
dodecamers and can accumulate intracellularly, show cor-
relation with synaptic loss and synaptic impairment in
many in vitro studies. Soluble oAβ binds preferentially to
synapses [10], and addition of oAβ to mouse hippocampal
slices results in inhibition of long-term potentiation [11].
This correlation has also been observed in vivo; the injec-
tion of oAβ directly into the hippocampus of rats resulted
in deficits in learning and memory [2,12,13]. While these
data suggest that soluble oAβ represents the neurotoxic
species in AD over insoluble fibrillar forms, the relation-
ships between oAβ, neurodegeneration, and cognitive de-
cline remain poorly defined, with most studies having only
examined the toxicity of oAβ in vitro or in vivo in mouse
models that possess soluble oAβ as well insoluble fAβ,
and Aβ plaques (see [13,14] for review). Data generated
from these mouse models produced results that can be
difficult to interpret due to the presence of multiple Aβ
conformations.
Mutations in amyloid precursor protein (APP) are ob-
served in patients with familial early-onset AD or demen-
tia caused by cerebral amyloid angiopathy. Of the APP
mutations causing AD or cerebral amyloid angiopathy,
four occur at the E693 position of the protein, the Dutch
(E693Q) [15], Arctic (E693G) [16] and Italian (E693K) [17]
mutations and a deletion (E693Δ) [18]. In contrast to the
pathological amyloid deposition observed in AD, patients
who carry the APP E693G (Arctic) or E693Δ variants show
little or no fibrillar Aβ as detected by amyloid imaging
[18,19]. Current imaging technologies cannot detect
soluble oAβ, which may be present in the brain, affect
synaptic function and lead to the cognitive deficits ob-
served in these patients. The present investigation soughtto examine the effects of soluble oAβ on neuronal and
synaptic structure in the APP E693Q (“Dutch”; DU)
mouse model of AD that displays intraneuronal accumula-
tion of soluble oAβ with no detectable plaques. This
mouse model expresses the E693Q mutation of the APP
[20]. Missense mutations in APP located near the middle
of the Aβ domain influence the propensity of Aβ to form
oligomeric assemblies by disrupting the salt bridges on the
protein that typically stabilize parallel β-pleated sheets and
favor fibril and plaque formation, thereby promoting the
formation and intraneuronal accumulation of oAβ [21].
Severe meningocortical vascular deposition of Aβ in pa-
tients with hereditary cerebral hemorrhage with amyloi-
dosis caused by the DU mutation has also been described.
Interestingly, these patients consistently develop cerebral
hemorrhages but rarely display significant parenchymal
amyloid plaque accumulation [22,23]. This was initially
proposed to be related to the ratio of Aβ42/40, with Aβ40
being the dominant species, however subsequent studies
revealed Aβ42 also plays a role in vascular amyloid
formation [22,23]. Recent work by Gandy and colleagues
indicates that the level of soluble oAβ in the DU mouse
model correlates with diminished performance in the
water maze compared to non-transgenic wild type (WT)
littermates at 12 months [20], indicating that DU mice,
which do not demonstrate extracellular deposits, exhibit
perturbed hippocampus-associated spatial learning and
memory.
Our goal was to complement these behavioral findings
by performing quantitative analyses of neuronal pathology,
including dendrite morphology, as well as spine and syn-
apse numbers in individual hippocampal CA1 neurons.
These morphological features of the neuron are the site of
critical memory forming processes [24-26]. Twelve month-
old DU mice were assessed, along with non-transgenic
WT littermates, for comparison of dendritic length and
complexity, and quantification of dendritic spines and syn-
apse densities. Structural components of synapses such as
postsynaptic density (PSD) length and synapse head dia-
meter of individual pyramidal CA1 neurons were also ex-
amined. We show that DU mice displayed morphological
changes in CA1 neurons compared to WT mice, including
significantly reduced dendritic arborization of apical den-
drites along with decreases in PSD length of synapses on
mushroom spines. These structural alterations to neurons
in DU mice support the concepts that the soluble oAβ
species have adverse effects at the synaptic level along with
major structural disturbances, and that changes at the
synapse correlate with early cognitive impairments in AD.
Results
Confirmation of oAβ in the DU mouse model
Before beginning the neuroanatomical comparisons in
DU and WT mice, it was first necessary to confirm
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mice. Using the 6E10 anti-Aβ antibody we found that
DU mice expressed amyloid and exhibited accumulation
of intracellular Aβ (Figure 1A, D) and not extracellular
plaques as in the TgCRND8 mice (Figure 1B, E), con-
firming results from previous studies [20,27]. No amy-
loid pathology was observed in WT mice (Figure 1C, F).
Effects of oAβ on dendritic length and arborization
We assessed whether CA1 neurons from DU mice
would display differences in dendritic length and com-
plexity compared to neurons from WT mice, and pre-
dicted that apical and basal dendrites from DU mice
would be atrophic, and display perturbed arborization
and complexity compared to WT mice. Representative
examples of CA1 dendritic arbor reconstructions and
dendrograms of WT and DU neurons are depicted in
Figure 2A and B. Dendritic measurements revealed a
significant decrease in the length of apical dendrites
(Figure 2C, t(15) = 2.828; p = 0.013) but not in basal den-
drites (Figure 2D, t(15) = 0.857; p = 0.405) in DU mice
compared to WT (Table 1). To characterize the bran-
ching characteristics of individual neurons and their ra-
dial complexity, we performed Sholl analysis on apical
and basal dendrites of DU and WT CA1 neurons. Sholl
analysis of apical dendritic length and intersections re-
vealed significant effect of genotype on the dendritic
length (Figure 2E, F(1, 168) = 6.31 p = 0.013) and intersec-
tions (Figure 2G, F(1, 168) = 0.82, p = 0.01) in DU dendrites
compared to WT mice. These differences were most pro-
nounced at a distance of 120 μm and 150 μm away fromFigure 1 APP/Aβ pathology in the hippocampus of Dutch mutant AP
were visualized using the 6E10 antibody. Intracellular APP/Aβ-like immunorea
amyloid plaques (black arrow) are evident in TgCRND8 APP transgenic mice (
A-C scale = 500 μm; D-F scale = 100 μm.the soma, respectively. When basal dendrites were ana-
lyzed there were no significant differences observed for
both basal dendritic length (Figure 2F, F(1, 112) = 0.01
p = 0.923) and basal intersections (Figure 2H, F(1, 112) =
6.31 p = 0.999) between DU and WT mice. Together these
data suggest that soluble oAβ primarily affects the apical
dendritic arbors, with no effect on basal dendrites of CA1
pyramidal neurons when it accumulates in situ. It remains
to be assessed whether these effects are the result of de-
creased input to the CA1 from other affected hippocam-
pal areas or a local effect in the CA1 region.
Effects of oAβ on spine density and spine subtype
With the dendritic atrophy observed in apical dendrites
in response to the accumulation of soluble oAβ, it is also
possible that there may be alterations in dendritic spine
density or the proportion of spine subtypes. We there-
fore analyzed WT and DU neurons for changes in the
density of dendritic spines. We compared overall spine
density of DU and WT mice, and also examined possible
changes in thin, stubby, and mushroom spines, separ-
ately (Figure 3; Table 1). We observed no significant
differences in the density of total, apical or basal stubby
and thin spines in DU mice compared to WT mice
(Figure 3C-H). When we analyzed total mushroom spine
density we found a slight decrease between Dutch mice
and controls (t(8) = 1.967; p = 0.085). When we separated
spines into apical and basal dendrites we observed a
decrease in apical but not basal mushroom spine density
(t(8) = 2.193; p = 0.06; and t(8) = 0.032; p = 0.975 respec-
tively); however, as above, this did not reach significance.P and TgCRND8 mutant APP transgenic mice. Aβ and APP species
ctivity (arrowhead) is evident in DU mice (A and D) while extracellular
B and E). No APP/Aβ immunoreactivity is seen in WT mice (C and F).
Figure 2 Alterations in neuronal morphology with amyloid pathology. Representative neuronal traces of WT and DU neurons and their
apical and basal dendrograms are represented in A and B, respectively. Significant differences were observed in apical but not basal length
(C and D). Sholl analysis revealed a significant decrease in apical dendritic length (E) and intersections at 120 μm and 150 μm away from the
soma, respectively, in DU neurons compared to WT (G), but this finding was not repeated for basal dendrites (F, H). Data represent group
mean ± SEM (n = 11 WT and 5 DU). *p < 0.05.
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separated into proximal (50–100 μm from the cell soma)
and distal (>100 μm from the cell soma), no differences
were observed, and these data were therefore pooled.Effects of oAβ on synapses
Next we asked whether oAβ affects the density of perfo-
rated and non-perforated synapses on spines from both
the stratum radiatum (SR) and the stratum lacunosum-
Table 1 Apical dendritic, spine and synapse morphology
from CA1 pyramidal neurons of DU and WT mice
Genotype
DU WT
Apical dendritic length (μm) 1277.65 ± 147.79 1507.37 ± 154.86
Spine density (Spines/μm)
Total 2.676 ± 0.164 2.674 ± 0.118
Thin 1.585 ± 0.307 1.548 ± 0.133
Stubby 1.114 ± 0.177 1.007± 0.097
Mushroom 0.199 ± 0.014 0.237± 0.012
Synapse density (μm3)
Total 2.897 ± 0.304 2.830 ± 0.250
Perforated 0.097 ± 0.013 0.123 ± 0.023
Non-perforated 2.800 ± 0.297 2.829 ± 0.250
Synapse morphology (μm)
PSD length 0.300 ± 0.007 0.327 ± 0.006
Head Diameter 0.529 ± 0.014 0.551 ± 0.006
Figure 3 No significant changes in dendritic spine density in DU mice
and DU dendrites in 3D with spine visualization (A & B). When spine dens
spines on apical and basal dendrites in DU and WT neurons (C-H). Analysis
not reach significance (I-K). Data represent group mean ± SEM. Scale bars =
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synapses were reconstructed (130/animal on average)
across serial EM sections using the disector method.
Analysis of the density of non-perforated and perforated
synapses from SR and SLM revealed no significant diffe-
rence between WT and DU mice (Figure 4A, B; Table 1).
Structural alterations to individual synapses were exam-
ined by measuring the maximum head diameter and PSD
lengths of synapses across DU and WT animals. When
average maximum head diameter of synapses was ana-
lyzed, no major differences in mean values was observed
(WT= 0.392 μm, DU= 0.393 μm, Figure 4C), and the
range of values did not change significantly for each geno-
type (WT = 0.143 – 0.942 μm, DU= 0.182 – 0.999 μm).
Similarly, we found that the means for PSD lengths for
each genotype were close to identical (WT = 0.243 μm,
DU= 0.238 μm, Figure 4D). When we determined the
range of PSD lengths for DU and WT mice, these were
also similar (WT = 0.094 – 0.609 μm, DU = 0.112 –
0.453 μm). Cumulative frequency curves of both syn-
apse head diameter and PSD lengths to compare theircompared to controls. Representative images of deconvolved WT
ity was analyzed, no changes were observed for total, thin, and stubby
of mushroom spines revealed a decrease in density however, this did
5 μm.
Figure 4 PSD length is significantly decreased in mushroom spines in DU mice. The synapse density of perforated and non-perforated
synapses in WT and DU mice remained unchanged (A & B), and the maximum head diameter of synapses and PSD lengths was also unchanged
across genotypes in the SR and SLM dendritic region (C & D, n = 10/genotype). When synapses only on mushroom spines in the SR were
analyzed, synapse head diameter remained constant, whereas a significant decrease in PSD length of DU synapses was observed (E & F, *p < 0.05,
two-tailed t-test, n = 5/genotype). Data represent group mean ± SEM.
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significant differences (Kolmogorov-Smirnov test, see
Additional file 1: Figure S1). When data were separated
according to either SR or SLM, we also saw no changes
to these synaptic parameters (data not shown).
We reasoned that there might be changes to the
synaptic characteristics on specific spine subtypes. We
chose to focus our investigation here on the mushroom
spine subtype since this spine subtype is implicated in
the formation and maintenance of memory [28,29]. Al-
though we did not observe any changes in maximum
head diameter and PSD length in Figure 4C & D, any
changes to synapses on mushroom spines may have been
masked by the pooling of our synapse measurements
from all spine subtypes. Therefore, we analyzed the
maximum head diameter and PSD length of mushroom
spines. When synapses on mushroom spines were ana-
lyzed separately in this way, we observed a significant de-
crease in PSD lengths for synapses on mushroom spinesin DU mice compared to WT with no change in maxi-
mum head diameter (Figure 4F, t(8) = 3.025; p = 0.016).
Discussion
Aβ and its proposed neurotoxicity has been the focus of
AD research since it was identified in the brains of AD
patients three decades ago [30,31]. The discovery that
Aβ has a variety of conformations, and the lack of cor-
relation between cognitive decline and plaque accumula-
tion, has prompted researchers to reassess the ‘amyloid
cascade hypothesis’ that dominated early AD research
[32]. Recent advances in early AD diagnosis have en-
abled amyloid PET imaging, using ligands such as flor-
betapir [33] and Pittsburgh Compound-B [34] to detect
Aβ deposits. However, these studies have also validated
that hippocampal neurodegeneration is unrelated to rate
of Aβ deposition [35]. The strong correlation between
soluble conformations of Aβ and cognitive impairments,
along with synaptic dysfunction and loss has shifted the
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Aβ conformations as the ‘toxic species’ [32]. Indeed,
monomeric and oligomeric forms of Aβ have been re-
ported to accumulate in synapses of AD brains as com-
pared to controls [36]. However, new tools and models
to discriminate between different Aβ aggregation states
have not been available until recently [37], and despite
reports of altered dendritic spine and synaptic morph-
ology in a variety of AD experimental models, there is
limited knowledge about how soluble oAβ may affect
these structural parameters in a model that does not also
accumulate amyloid plaques.
In the current study, we have utilized a mouse model
of AD that expresses the Dutch variant of APP. In silico
modeling of Aβ fibrillization [38], cell-free aggregation
experiments [39] and in vitro experiments [40,41]
showed that the Dutch mutation increased fibrillization
of Aβ. Indeed, the Dutch mutation increases deposition
of Aβ in vascular tissue but has the opposite effect in
parenchyma of the transgenic mice, as is seen in patients
carrying this mutation [42]. In contrast to the mice used
in the Herzig study, which expressed both normal and
Dutch APP, the DU mice we used in the current study
expressed Dutch APP and only produces soluble oAβ,
with no detectable plaques up to 30 months of age [20]
(Figure 1). The DU mice display cognitive deficits in
spatial memory tasks at 12 months of age, indicating
that soluble oAβ may be inducing these effects in the ab-
sence of fAβ. Here we demonstrate that CA1 pyramidal
neurons exhibit changes to neuronal morphology and
total spine and synapse density. We selected the CA1 re-
gion for analysis since it is implicated in long-term con-
textual memory retrieval [43,44], which is affected in AD
[45]. Neocortical pyramidal neurons possess extensive
apical and basal dendritic trees, which integrate informa-
tion from thousands of excitatory and inhibitory synaptic
inputs [6]. The morphological features of a dendrite,
such as its length and complexity, can influence how a
neuron processes and transmits information [46-49],
and many in vivo studies do report neuronal atrophy
with proximity to fAβ in the brain and subsequent func-
tional deficits (see [6] for review). The effects of oAβ are
less well characterized, although oAβ has been implicated
in alterations to overall dendritic spine number and type
in AD. Most studies on spines in AD models report either
a spine loss, or a shift in the proportion of thin, stubby, or
mushroom spine types, which are proposed to have
unique roles, complementing their distinctive morphology
[3,50-52]. For example, thin spines contain a predomin-
antly greater number of the N-methyl-D-aspartate glutam-
ate receptors (NMDARs) compared to large, mushroom
spines that contain more 2-amino-3-(3-hydroxy-5-methyl-
isoxazol-4-yl)propanoic acid receptors (AMPARs), making
synapses on mushroom spines functionally stronger [28].This suggests that the more plastic, thin spines are linked
to learning, whereas mushroom spines may represent
more stable, ‘memory’ spines [28,29]. A growing number
of reports support the notion that spines and synapses are
the initial site of Aβ-mediated neurotoxicity [24-26,53],
and it is probable that more dramatic oAβ-driven distur-
bances in DU mice are occurring at the synaptic receptor
level, which we did not examine here. Excitatory gluta-
matergic NMDARs, AMPARs and other critical synaptic
proteins may be affected in DU mice, with reduced ex-
pression and altered distribution of NMDA and AMPA
receptors. Other in vitro and ex vivo experimental models
have reported direct binding of soluble Aβ to synaptic
proteins at the PSD [53-55] and these observations are
supported by the decrease in PSD length in DU mice we
observed in this study.
The significant decrease we observed in PSD length of
synapses only on apical mushroom spines may reflect dis-
turbances in synaptic function and memory impairment
in the presence of oAβ. A similar finding was reported by
Nicholson et al. (2004) in their study of aged, learning-
impaired Long Evans rats. These authors reported a
significant (~30%) decrease in PSD length of CA1 SR
synapses in the impaired group compared to control rats
[56], and noted that the decrease was only apparent in
perforated synapses, which are defined by a discontinuity
of the electron dense plate on the post-synaptic mem-
brane into two or more parts [57,58]. Although the
decrease in PSD length we observed in DU mice for
synapses in the same brain region were not as dramatic,
our data is supported by this study as perforated synapses
typically occur only on mushroom spines implicated in
memory formation [28,29]. This is because the shape of
the PSD can increase in complexity with increasing spine
size [57]. Furthermore, perforated synapses have been pro-
posed to enhance synaptic efficacy by increasing the sur-
face area for receptor activation [56,59,60]. A decrease in
PSD length would therefore reduce glutamate receptor
content and impair synaptic efficacy, leading to functional
disturbances [60]. Within the context of the current study,
a decrease in PSD length suggests that hippocampal
perforated synapses are selectively affected by soluble
oAβ, correlating with the observed cognitive deficits in 12
month-old DU mice. Alternatively, it is possible that
although we did not observe any changes in perforated
and non-perforated synapses or total synapse number, the
DU mice may have an increased proportion of AMPA-
type ‘silent’ synapses. These express NMDARs, but lack
functional AMPARs [61], and do not generate a synaptic
response following glutamate release at normal resting
membrane potentials [62]. In electron micrographs, they
are structurally identical to functional synapses, and can
only be distinguished by a lack of AMPA immunore-
activity [62-67]. When a study by Geinisman et al. (2004)
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synapses, and total synapse numbers in the SR dendritic
domain of CA1 neurons of cognitively impaired, aged rats
compared to control rats, they argued that this may be
due to an increased proportion of silent synapses [62].
Because silent synapses may become functional during
postnatal development and the induction of hippocampal
long-term potentiation, it is also possible that functional
synapses in CA1 pyramidal neurons become increasingly
silent with age [62], leading to a loss of synaptic activity
without diminished synapse numbers. Further support for
an oAβ-driven increase in silent synapses comes from
other work using both the transgenic mice carrying the
Swedish APP mutation and the external application of
oAβ to rat cortical neurons, which found that oAβ altered
the distribution and reduced the expression of Ca2+/
calmodulin-dependent protein kinase II (CaMKII) [68].
CaMKII is a critical scaffolding protein highly enriched at
PSDs that is required for transporting AMPARs to the
synapse, and switching synapses from silent to functional
through AMPA delivery [69,70]. A reduction in the ex-
pression of CaMKII following oAβ exposure therefore
provides a mechanism for increased silent synapses to
occur. Interestingly, no changes in dendritic spine density
were also found by another group using oAβ externally
applied to rat cortical cultures compared to controls [68].
Further analysis of the DU mice using immunogold elec-
tron microscopy (EM) will help to clarify if soluble oAβ
accumulated in situ influences the proportion of silent
synapses or dramatically alters the expression and dis-
tribution of synaptic receptors in the CA1. Additional be-
havioral and immunogold EM analyses in older DU mice
(18 and 24 month-old) will also reveal whether their cog-
nitive deficit and neuropathology worsens with age.
Conclusions
In the present study, we report that accumulation of so-
luble oAβ only in DU mice leads to discernible morpho-
logical changes to neurons, with an increase in dendritic
atrophy accompanied by a decrease in PSD length that
may be responsible for the cognitive impairment seen in
these mice. Many in vitro studies on the putative neuro-
toxicity of oAβ to dendrites, spines, and synapses that do
report changes to neuronal morphology have used syn-
thetic oAβ preparations that may not accurately match
the toxicity profile of naturally occurring oAβ species oc-
curring in vivo [71]. In addition, mouse models of AD up
to this point have expressed both soluble oAβ and in-
soluble fibrillar species, hindering clarification of the
‘conformation-specific’ neurotoxic effects of Aβ. Interes-
tingly, in these models of AD, loss of dendritic spines or
synaptic proteins has been observed prior to Aβ plaque
deposition or in brain areas without Aβ plaques (reviewed
in [72]). Methodological inconsistencies and the lack ofadequate mouse models to assess only oAβ in situ prior to
this point, means that care should be taken in the inter-
pretation of individual AD studies. Importantly, this also
highlights the need for consistent methodological prac-
tices across AD research for improving and accelerating
our understanding of the disease. We propose that the
DU mouse model of AD represents a useful tool for the
assessment of oAβ-mediated synaptic changes, based on
our findings of detectable synaptic changes parallel to the
onset of cognitive deficits in this model. Future studies
using transgenic models expressing the Dutch, Arctic or
E693Δ variants of APP and aimed at the development of
imaging techniques to detect oAβ, in the absence of Aβ
deposits would enable correlation of these synaptic
changes with a potential clinical diagnostic tool.Methods
Experimental animals
Male and female 12-month old mice were used in the
study. All animals were group housed in micro-isolator
cages under a 12-hour light/dark cycle and given ad libi-
tum access to food and water. The DU mice used in the
study contain the human APP gene harboring the Dutch
mutation (APP E693Q) under control of the Thy1 pro-
moter [20]. These mice exhibit intraneuronal accumula-
tion of soluble oAβ with no detectable plaques, in addition
to the appearance of amyloid-laden cerebral vessels and
occasional extravasation of blood from vessels without
gross hemorrhage [20]. TgCRND8 mice express double
mutations within the human APP 695 isoform (Swedish
K670M/N671L and Indiana V717F mutations) under con-
trol of the hamster prion promoter. These mice overex-
press human Aβ by 3–4 months, have a high Aβ42/Aβ40
ratio and exhibit plaque deposition, activated microglia,
neuronal loss and cognitive deficits as early as 3 months of
age [73-75]. All animal procedures were conducted in ac-
cordance with the National Institute of Health Guidelines
for the Care and Use of Experimental Animals and were
approved by the Institutional Animal Care and Use Com-
mittee at the Icahn School of Medicine at Mount Sinai.
For cell loading and EM experiments, we included n = 5
mice/group and imaged a minimum of 5 neurons/mouse
with DU mice being compared to WT mice.Mouse perfusions
Mice were anesthetized and perfused with 1% paraformal-
dehyde (PFA) followed by 4% PFA with 0.125% glutaral-
dehyde as described previously [75,76]. The brains were
removed, hemisected, postfixed overnight, and sectioned
on a Vibratome (Leica VT1000S) into 200 μm-thick sec-
tions for cell loading experiments and 250 μm for EM. All
sections were stored at 4°C in phosphate buffered saline
(PBS) until ready for use.
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Free-floating hippocampal brain slices from DU and WT
mice were processed for immunohistochemistry for Aβ
using the 6E10 anti-Aβ antibody (Covance) as previously
described [27,77]. The mAb 6E10 is specific for amino
acids 1–16 of human Aβ, with the epitope lying within
amino acids 3–8 of Aβ (EFRHDS). Brain slices from
TgCRND8 mice that accumulate dense cored Aβ plaques
[73], were stained in parallel as a positive control. Im-
ages were acquired on a Zeiss Axiophot 2 microscope
equipped with a motorized stage and video camera sys-
tem using 2.5x/0.075 N.A., Plan-Neofluar and a 40x/1.3
N.A., Plan-Neofluar oil immersion objectives.
Intracellular dye injections
For intracellular injections, sections were incubated in
4’,6-diamidino-2-phenylindole (DAPI; Vector Labs) for 5
min to reveal the cytoarchitectural features of the pyra-
midal layer of CA1 of the hippocampus. The sections were
then mounted on nitrocellulose paper and immersed in
ice-cold 0.1 M PBS. Pyramidal neurons in the CA1 were
subjected to an intracellular iontophoretic injection of 5%
Lucifer Yellow (Molecular Probes) in distilled water under
a direct current of 3–8 nA until dye had completely filled
distal processes [75,76,78]. Five to 10 neurons were
injected per slice and placed far enough apart to avoid
overlapping of their dendritic trees. Brain sections were
then mounted on gelatin-coated glass slides and cover
slipped in Fluoromount G slide-mounting media (Cell Lab
Beckman Coulter).
Neuronal and dendritic reconstruction
To be included in the analysis, a loaded neuron had to sa-
tisfy the following criteria: (1) reside within the pyramidal
layer of the CA1 as defined by cytoarchitectural characte-
ristics; (2) demonstrate complete filling of dendritic tree,
as evidenced by well-defined endings; and (3) demonstrate
intact tertiary branches, with the exception of branches
that extended beyond 50 μm in radial distance from the
cell soma [75,76,78]. Neurons meeting these criteria were
reconstructed in 3-dimensions (3D) with a 40×/1.4 N.A.,
Plan-Apochromat oil immersion objective on a Zeiss
Axiophot 2 microscope equipped with a motorized stage,
video camera system, and Neurolucida morphometry soft-
ware (MBF Bioscience). Using NeuroExplorer software
(MBF Bioscience) total dendritic length, number of inter-
sections, and the amount of dendritic material per radial
distance from the soma, in 30-μm increments [79] were
analyzed in order to assess morphological cellular diversity
and potential differences between the animal groups.
Confocal microscopy and spine acquisition
Using an approach that precludes sampling bias of spines,
CA1 dendritic segments were selected with a systematic-random method [80,81]. Dendritic segments, 20–25 μm
in length, were imaged on a Zeiss CLSM 510 microscope
(Zeiss) using a 100×/1.4 N.A. Plan-Apochromat objective
with a digital zoom of 3.5 and an Ar/Kr laser at an ex-
citation wavelength of 488 nm. All confocal stacks were
acquired at 512 × 512 pixel resolution with a z-step of
0.1 μm, a pinhole setting of 1 Airy unit and optimal
settings for gain and offset. All confocal stacks included
approximately 1 μm above and below the identified den-
dritic segment. On average 6 z-stacks were imaged per
neuron, 3 for the apical dendritic tree and 3 for the basal
dendritic trees. To be optically imaged, a dendritic seg-
ment had to satisfy the following criteria: (1) the entire
segment had to fall within a depth of 50 μm; (2) dendritic
segments had to be either parallel or at acute angles to the
coronal surface of the section; and (3) segments could not
overlap other segments that would obscure visualization
of spines [80,81]. Confocal stacks were then deconvolved
using an iterative blind deconvolution algorithm (AutoDe-
blur version 8.0.2; MediaCybernetics).
Spine analysis
After deconvolution, confocal stacks were analyzed with
NeuronStudio [82-84] (http://research.mssm.edu/cnic/)
to examine global and local morphometric characteris-
tics of dendrites and spines such as dendritic spine dens-
ities and dendritic spine shape. This software allows for
automated digitization and reconstructions of neuronal
morphology in 3D from multiple confocal stacks on a
spatial scale and averts the subjective errors encountered
during manual tracing using a Rayburst-based spine ana-
lysis [82-84]. Spines were classified as ‘stubby’ if they
had a head to neck diameter ratio less than 1.1, ‘thin’
spines were identified by a head to neck diameter ratio
greater than 1.1 and a maximum head diameter less than
0.4 μm. ‘Mushroom’ spines were identified by a head to
neck diameter ratio greater than 1.1 and a maximum
head diameter greater than 0.4 μm [85]. Five animals per
genotype, five neurons per mouse and three apical and
three basal dendritic segments per neuron were analyzed
with each segment manually inspected and appropriate
corrections made using the NeuronStudio interface.
Electron microscopy
Coronal sections (250 μm-thick) encompassing the CA1
region of the hippocampus were prepared for EM as re-
ported previously [86]. Briefly, slices were cryoprotected
in graded phosphate buffer/glycerol washes at 4°C, and
manually microdissected to obtain blocks containing the
CA1 region. The blocks were rapidly freeze-plunged into
liquid propane cooled by liquid nitrogen (−190°C) in a
Universal cryofixation System KF80 (Reichert-Jung) and
subsequently immersed in 1.5% uranyl acetate dissolved
in anhydrous methanol at −90°C for 24 hours in a
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raised from −90 to −45°C in steps of 4°C/hour, washed
with anhydrous methanol, and infiltrated with Lowicryl
resin (Electron Microscopy Sciences) at −45°C. The resin
was polymerized by exposure to ultraviolet light (360 nm)
for 48 hours at −45°C followed by 24 hours at 0°C. Block
faces were trimmed and ultrathin sections (90 nm) were
cut with a diamond knife (Diatome) on an ultramicrotome
(Reichert-Jung) and serial sections of at least 5 sections
were collected on formvar/carbon-coated nickel slot grids
(Electron Microscopy Sciences).
Quantitative analyses of synapse density, PSD length, and
spine head diameter
For synapse quantification, serial section micrographs
were imaged at 15,000x on a Hitachi H-7000 transmission
electron microscope using an AMT Advantage CCD ca-
mera (Advanced Microscopy Techniques). Twelve sets of
serial images across the same set of 5 consecutive ultra-
thin sections were taken from the SR and SLM of the
hippocampus CA1 field and imported into Adobe Photo-
shop (version CS5, Adobe Systems). To obtain a stereo-
logically unbiased population of synapses for quantitative
morphologic analysis, we used a disector approach on
ultrathin sections as in previous reports [87,88]. Briefly, all
axospinous synapses were identified within the first and
last 2 images of each 5-section serial set, and counted if
they were contained in the reference image but not in the
corresponding look-up image. To increase sampling effi-
ciency, the reference image and look-up image were then
reversed; thus each animal included in the current study
contributed synapse density data from a total of 30 dis-
sector pairs. The total volume examined was 11.317 μm3,
and the height of the disector was 180 nm. Axospinous
synapse density (per μm3) was calculated as the total num-
ber of counted synapses from both images divided by the
total volume of the disector. The criteria for inclusion as
an axospinous synapse included the presence of synapticFigure 5 Identification of axospinous synapses using the disector me
disector method (A & B). Only asymmetric axospinous synapses that are p
panel were counted. Synapses present in both panels (green) were not inc
by the presence of a discontinuity (or more than one) within the postsyna
diameter of synapses and PSD length were measured as indicated in D (scvesicles in the presynaptic terminal and a distinct asym-
metric PSD separated by a clear synaptic cleft (Figure 5A
& B). The synapse density was calculated as the total
number of counted synapses divided by the total volume
of the disectors used. For a synapse to be scored as perfo-
rated it had to display two or more separate PSD plates
(Figure 5C). Spine head diameter and PSD length were of
interest because they are indicative of spine plasticity and
glutamate receptor representation [88]. For instance,
small, thin spines are thought to be more motile and
plastic than larger mushroom spines [88-90]. PSD length
measurements and maximum spine head diameter were
determined using a method previously described [88].
Briefly, all axospinous synapses in the middle portion of
three serial sections were identified. Then, for each syn-
apse, the longest PSD length and spine head diameter in 3
serial sections was identified and measured (Figure 5D). If
the synapse only spanned 2 out of the 3 serial sections,
the longest PSD and head diameter from 2 sections was
measured. For the smallest class of synapses that were
only present in 1 serial section, measurements were taken
in that section. According to Hara et al. (2011), while this
method of measuring PSD lengths and head diameter re-
sults in a 5.5% underestimation of true PSD length and
head diameter, it applies across all animals and is not likely
to bias systematically the outcome of group comparisons
[88]. For perforated synapses, the lengths of all PSD
segments were summed and the total length was used in
the statistical analyses. Approximately 130 synapses were
counted per animal.
Statistics
All statistical analyses were performed using GraphPad
Prism 5 software (GraphPad Software Inc). For neuron
morphology and spine and synapse data, values for
single cells were averaged for each animal and then per
genotype and analyzed with GraphPad Prism 5. For the
mean apical and basal dendritic length, and all spine andthod. Electron micrographs depicting synapses counted using the
resent in the reference panel (purple or blue), but not in the look-up
luded in the analysis. Perforated synapses (C, purple) were classified
ptic density (PSD) as shown by the vector arrows. Maximum head
ale bars = 500 nm).
Price et al. Molecular Neurodegeneration 2014, 9:41 Page 11 of 13
http://www.molecularneurodegeneration.com/content/9/1/41synapse data, a two-tailed Student’s t-test was per-
formed. Sholl analysis was performed on apical and basal
dendrites for total dendritic length, number of inter-
sections and amount of dendritic material. Both Sholl
and intersection analyses were analyzed using two‐way
ANOVA followed by Bonferroni’s post‐hoc tests. To de-
termine if the frequencies of different sized dendritic
synapses differed between DU and WT mice, cumulative
frequency curves of maximum spine head diameter and
PSD length were examined using the Kolmogorov-
Smirnov test. There were no statistical differences bet-
ween male and female mice for these data, therefore
sexes were grouped together. The statistical significance
level for all data was set at an α level of 0.05 and all data
were represented as mean ± SEM.
Additional file
Additional file 1: Figure S1. Cumulative frequency curves of synapse
head diameter and PSD length. Cumulative frequency curves of synapse
head diameter (A) and PSD length (B) of synapses on CA1 hippocampal
neurons in DU and WT mice. No shift in the distribution of head
diameter or PSD length of CA1 synapses was observed in DU and
WT mice.
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